Global Research Initiation of Coverage ab 28 July 2026 Integra LifeSciences Holdings Corp Cleaning Up. Neutral at $19 PT. Our View: We initiate coverage of IART with a Neutral rating and a $19 price target. Despite recent regulatory and operational difficulties and a historically high leverage profile, IART's fundamental building blocks are relatively sound: IART is a category leader across end- markets that are themselves structural MSD growers, so the Street's expectations on organic numbers (+2-3% from 3 ...